Gastroesophageal reflux disease (GERD) is a chronic condition in which gastric contents flow backward through a dysfunctional lower esophageal sphincter (LES) and damage the esophageal mucosa. It affects roughly 20% of adults in the US, making it one of the most common GI diagnoses in both outpatient and inpatient nursing. The classic presentation — heartburn and regurgitation — is only part of the picture. Many patients present with atypical symptoms: hoarseness, chronic cough, or dental erosion, a syndrome called laryngopharyngeal reflux (LPR) that most nursing resources omit entirely. GERD also sits on a progression continuum that can end in esophageal adenocarcinoma through Barrett’s esophagus.
This reference covers the full scope: LES dysfunction mechanics, erosive vs. non-erosive disease, typical vs. atypical presentations, diagnostics including ambulatory pH monitoring, the Los Angeles classification of erosive esophagitis, Barrett’s esophagus surveillance intervals, priority nursing interventions with rationale, PPI pharmacology and its critical interaction with clopidogrel, and post-surgical nursing care for Nissen fundoplication and the LINX device. For peptic ulcer disease driven by H. pylori, see the peptic ulcer disease nursing reference. For GI bleeding from esophageal erosions or varices, see the GI bleed nursing reference.
| Quick reference | Details |
|---|---|
| Definition | Chronic retrograde flow of gastric contents through a defective LES causing mucosal damage |
| Primary mechanism | Transient LES relaxations (tLESR) or persistently low resting LES pressure |
| Classic symptoms | Pyrosis (heartburn), regurgitation, water brash |
| Atypical/LPR symptoms | Hoarseness, globus, chronic cough, dental erosion, laryngitis |
| Alarm symptoms | Dysphagia, odynophagia, unintentional weight loss, GI bleeding → immediate EGD |
| First diagnostic step | Empiric PPI trial (4–8 weeks) |
| Gold-standard diagnostic | 24-hour ambulatory pH monitoring |
| First-line treatment | PPI 30–60 min before first meal; lifestyle modification |
| Key complication | Barrett’s esophagus → esophageal adenocarcinoma |
| Nursing priority | Symptom control, medication adherence, HOB elevation, aspiration prevention |
Pathophysiology
The LES is a 3–4 cm zone of tonically contracted smooth muscle at the gastroesophageal junction. Resting LES pressure normally sits between 10–45 mmHg — enough to resist gastric pressure. GERD results when this barrier fails by one of three mechanisms:
Transient LES relaxations (tLESR): The dominant mechanism in most GERD patients. The LES briefly relaxes independent of swallowing, triggered by gastric distension and mediated through the vagus nerve. These episodes are normal in small numbers (physiologic reflux), but GERD patients have a much higher frequency of tLESRs, particularly after large meals.
Hypotensive LES: A resting LES pressure below 10 mmHg allows continuous retrograde flow. This is characteristic of severe erosive disease and often associated with hiatal hernia. When the LES migrates above the diaphragmatic hiatus in a hiatal hernia, it loses the mechanical support of diaphragmatic contraction and crural compression, further reducing the antireflux barrier.
Impaired esophageal clearance: Under normal conditions, peristaltic contractions sweep refluxed acid back into the stomach within 1–2 swallows, and bicarbonate-rich saliva neutralizes residual acid. In GERD patients, ineffective esophageal motility and reduced salivary output (worsened by mouth breathing, smoking, and sleep) prolong acid contact time, amplifying mucosal injury.
Erosive vs. non-erosive reflux disease (NERD): Roughly 50–70% of GERD patients have NERD — symptoms and abnormal pH studies without visible mucosal breaks on endoscopy. NERD patients report equivalent or worse symptom burden than erosive patients, but their mucosa is intact. This distinction matters clinically: NERD patients respond less predictably to PPIs, and a normal endoscopy does not rule out GERD.
Clinical presentation
Typical symptoms
- Pyrosis (heartburn): Retrosternal burning that rises toward the throat, worsened by large meals, lying supine, bending forward, and NSAIDs or alcohol. Classically improves with antacids.
- Regurgitation: Effortless return of sour or bitter gastric contents to the mouth or throat, without nausea or retching. This distinguishes GERD regurgitation from vomiting.
- Water brash: Sudden flooding of the mouth with clear, slightly salty fluid from reflex salivary hypersecretion. Often confused with regurgitation.
Atypical and extraesophageal symptoms (LPR)
Laryngopharyngeal reflux occurs when gastric contents bypass the upper esophageal sphincter and reach the larynx and pharynx. LPR and GERD are now considered distinct — though overlapping — conditions. Critically, nearly 100% of LPR patients report hoarseness, whereas virtually no classic GERD patients do. LPR typically occurs during daytime upright activity, while classic GERD worsens at night in the recumbent position.
| Symptom type | Classic GERD | LPR (silent reflux) |
|---|---|---|
| Pyrosis (heartburn) | Present in most | Absent in up to 40% |
| Regurgitation | Common | Less prominent |
| Hoarseness | Rare | Cardinal symptom |
| Globus (lump in throat) | Uncommon | Common |
| Chronic throat clearing | Uncommon | Very common |
| Chronic cough | Occasional | Prominent |
| Dental erosion | Rare | Can occur with chronic exposure |
| Symptom timing | Nocturnal/recumbent | Daytime/upright |
| LES dysfunction | Lower LES dominant | Upper LES dominant |
The Reflux Symptom Index (RSI) is a validated 9-item patient-reported questionnaire; a score above 10 (maximum 45) is highly suggestive of LPR pathology. Nursing assessment should screen for hoarseness, globus, and chronic cough in any patient with unexplained upper respiratory symptoms.
Diagnostics
Empiric PPI trial: The standard first step for uncomplicated, typical GERD symptoms. A 4-week trial of once-daily PPI with symptom resolution supports a clinical diagnosis. EGD is not required unless alarm symptoms are present.
Alarm symptoms requiring immediate EGD: Dysphagia, odynophagia, unintentional weight loss, hematemesis, melena, iron-deficiency anemia, and onset after age 60. These features may indicate esophageal stricture, ulcer, or malignancy.
Upper endoscopy (EGD): Visualizes mucosal breaks, Barrett’s changes, strictures, and mass lesions. Required for alarm symptoms, failed PPI trial, and annual surveillance in confirmed Barrett’s esophagus.
Ambulatory pH monitoring: The gold standard for confirming pathologic acid exposure. Two methods:
- 24-hour pH catheter: A thin probe is placed transnasally and positioned 5 cm above the LES. It records pH continuously over 24 hours while the patient maintains a symptom diary. Useful for correlating symptoms with acid episodes.
- Bravo wireless pH capsule: A small capsule is clipped to the esophageal wall during endoscopy and transmits pH data wirelessly for 48–96 hours. Better tolerated than catheter; patients can eat and sleep normally. The capsule detaches spontaneously within 7–10 days.
Esophageal manometry: Measures LES resting pressure and peristaltic contraction patterns. Required before anti-reflux surgery to rule out achalasia or major motility disorders (a dysfunctional esophagus cannot tolerate a wrap).
Complications
Erosive esophagitis: Los Angeles classification
| Grade | Endoscopic finding | Recommended PPI duration |
|---|---|---|
| A | One or more mucosal breaks ≤5 mm, not crossing between folds | 4 weeks standard dose |
| B | One or more mucosal breaks >5 mm, not crossing between folds | 4 weeks standard dose |
| C | Mucosal breaks crossing between ≥2 folds, <75% of esophageal circumference | 8 weeks standard dose |
| D | Mucosal breaks involving ≥75% of esophageal circumference | 8 weeks standard dose; consider surgery evaluation |
Barrett’s esophagus
Chronic acid exposure drives metaplasia: the normal stratified squamous epithelium of the distal esophagus is replaced by intestinal-type columnar epithelium containing goblet cells. Barrett’s esophagus is the single most important risk factor for esophageal adenocarcinoma (EAC). Diagnosis requires at least 1 cm of visible columnar-lined esophagus with biopsy confirming intestinal metaplasia with goblet cells, confirmed by a second expert pathologist.
Annual progression risk to EAC by dysplasia grade:
- Nondysplastic BE (NDBE): 0.06–0.31% per year
- Indefinite for dysplasia: ~1.5% per year (to HGD or EAC)
- Low-grade dysplasia (LGD): ~0.7–9.1% per year
- High-grade dysplasia (HGD): endoscopic eradication therapy recommended
Surveillance intervals (ACG guidelines):
- NDBE <3 cm: every 5 years
- NDBE ≥3 cm: every 3 years
- Indefinite for dysplasia: repeat EGD within 6 months after intensifying PPI, then annually
- LGD (surveillance option): 6 months, then 12 months, then annually
- HGD: endoscopic eradication therapy (radiofrequency ablation preferred over surveillance)
Radiofrequency ablation (RFA): For LGD and HGD, RFA is the standard endoscopic eradication therapy. In the SURF trial, 1.5% of treated LGD patients progressed to HGD or EAC at 3 years versus 26.5% in the surveillance group. Post-RFA surveillance follows a compressed schedule (3, 6, and 12 months after complete eradication, then annually).
Other complications
- Esophageal stricture: Repeated cycles of inflammation and healing deposit collagen, narrowing the lumen. Presents as progressive solid-food dysphagia. Treated with endoscopic dilation.
- Aspiration pneumonia: Nocturnal reflux and microaspiration can cause recurrent pneumonia, especially in patients with impaired gag reflex or neurologic compromise.
Nursing interventions
| Intervention | Rationale | Timing/frequency |
|---|---|---|
| Elevate HOB 30–45° | Gravity prevents retrograde acid flow; reduces nocturnal aspiration risk | Continuous; use foam wedge or adjustable bed frame — not extra pillows alone |
| Avoid supine position 2–3 hours after meals | Postprandial period has highest tLESR frequency; supine positioning eliminates gravity barrier | After each meal; educate patient on meal-to-bed timing |
| Encourage small, frequent meals (4–6/day) vs. large meals | Large meals increase gastric distension, the primary trigger for tLESR episodes | At every meal; reinforce during patient teaching |
| Counsel on trigger foods | Fatty foods, chocolate, caffeine, alcohol, peppermint, and citrus reduce LES pressure or increase acid secretion | During patient education; provide written list |
| Weight reduction counseling | 5–10% body weight reduction significantly decreases GERD symptom frequency and severity; abdominal adiposity increases intragastric pressure | Each encounter; refer to dietitian if BMI >30 |
| Smoking cessation support | Nicotine relaxes LES and reduces salivary bicarbonate production, impairing acid clearance | Each encounter; refer to cessation program |
| Administer PPI 30–60 min before first meal | PPIs are prodrugs activated only by acid secretion during active pumping; timing with meals ensures maximum parietal cell activation | Once or twice daily per order; document timing |
| Avoid crushing or splitting PPI capsules | Enteric coating protects the prodrug from premature acid activation in the stomach | Each administration |
| H. pylori screen before long-term PPI initiation | PPIs suppress H. pylori density and urease activity, reducing test sensitivity; if H. pylori is present and untreated, PPI therapy alone risks masking infection | Order/confirm before starting therapy; urea breath test requires 2-week PPI hold |
| Monitor for PPI-clopidogrel interaction | Omeprazole and esomeprazole competitively inhibit CYP2C19, the same enzyme required to activate clopidogrel to its active antiplatelet form; this reduces clopidogrel efficacy | On admission review for patients on dual antiplatelet therapy; prefer lansoprazole, pantoprazole, or rabeprazole |
| Monitor for PPI adverse effects | Long-term use: hypomagnesemia, C. difficile risk, vitamin B12/iron malabsorption, rebound hypersecretion on discontinuation | Electrolytes (Mg²⁺) per protocol; B12 annually on long-term PPI |
| Post-fundoplication: monitor for dysphagia | Short-term dysphagia is expected from perioperative edema and wrap tension; dysphagia persisting >3 months may indicate wrap slippage and requires barium swallow | Every meal interaction in immediate post-op; reassess at follow-up visits |
| Post-fundoplication: gas-bloat syndrome education | The wrap prevents belching and vomiting; patients accumulate gas; self-limiting in 2–4 weeks but distressing without preparation | Preoperatively and immediately post-op; advise low-gas diet |
| LINX device: MRI restrictions | LINX is a magnetic device; MRI is conditionally safe only under specific manufacturer protocols; unrestricted MRI can dislodge or damage the implant | Reinforce at every care encounter; document in medical record and medication reconciliation |
| Teach-back on lifestyle modifications | Confirms patient understanding; lifestyle change is the only durable non-pharmacologic control | Before discharge and at each follow-up |
Post-operative diet progression (Nissen fundoplication)
Standard post-op diet follows a phased approach to allow the surgical wrap to heal:
- Days 1–7: Clear liquids and full liquids; no carbonated beverages
- Weeks 2–4: Soft, moist foods (scrambled eggs, yogurt, bananas); chew thoroughly; no large bites
- Week 4–6: Gradual reintroduction of solid foods; avoid tough meats and bread initially
- Long-term: Avoid foods that cause excess gas (carbonated drinks, beans, broccoli, cabbage); eat slowly; avoid drinking large volumes with meals
Medications
| Medication class | Drug names | Mechanism | Key nursing considerations |
|---|---|---|---|
| PPI (first-line) | Omeprazole, pantoprazole, lansoprazole, esomeprazole, rabeprazole | Irreversibly blocks H⁺/K⁺-ATPase on parietal cells | Administer 30–60 min before first meal; avoid omeprazole/esomeprazole with clopidogrel; screen for H. pylori before starting; monitor Mg²⁺ on long-term use |
| H2 receptor antagonist | Famotidine | Blocks H2 receptors, reducing histamine-stimulated acid secretion | Less potent than PPIs; tachyphylaxis (tolerance) develops with scheduled use within days; better for PRN symptom relief or nighttime dosing adjunct |
| Antacid | Calcium carbonate, magnesium hydroxide/aluminum hydroxide | Directly neutralizes gastric acid | Fastest onset (minutes); calcium carbonate can cause rebound acid secretion with excessive use; separate antacids from other oral medications by ≥2 hours (binds drugs) |
| Alginate-based preparation | Gaviscon (sodium alginate + sodium bicarbonate) | Forms viscous raft on top of gastric contents, providing mechanical barrier at GEJ | Particularly effective for postprandial symptoms; take after meals and at bedtime |
| Prokinetic | Metoclopramide | D2 antagonist; increases LES tone, accelerates gastric emptying | Reserve for gastroparesis-complicated GERD; FDA black box warning for tardive dyskinesia with long-term use (>12 weeks); avoid in Parkinson’s disease |
| Sucralfate | Sucralfate | Coats and protects esophageal/gastric mucosa | Take on empty stomach; separates from other medications; limited role in GERD vs. PUD |
Barrett’s esophagus nursing considerations
Patients with confirmed Barrett’s esophagus require structured surveillance because most will never develop cancer — but those who do progress through a defined dysplasia sequence. Nursing education focuses on three points: why surveillance matters even when they feel well, what to expect from endoscopic procedures (including RFA), and the lifestyle modifications that may slow progression (continued PPI use even in asymptomatic patients, weight management, smoking cessation).
RFA patients require preoperative education about the procedure (a balloon or focal catheter delivers radiofrequency energy to ablate abnormal mucosa), post-procedure expectations (chest discomfort, odynophagia for 5–10 days, liquid diet), and the importance of completing the full surveillance schedule. Complete eradication of intestinal metaplasia (CEIM) is the target — but residual islands of metaplasia can persist and require repeat treatment.
Dysplasia grading must be confirmed by two expert pathologists due to significant interobserver variability. Nursing documentation should reflect any upgrades or downgrades in dysplasia grade at each surveillance interval, as this changes the management algorithm.
NCLEX tips
-
PPI timing is a classic NCLEX question: PPIs should be administered 30–60 minutes before the first meal of the day, not at bedtime, not with food. If a patient is on twice-daily dosing, the second dose goes 30–60 minutes before dinner.
-
Alarm symptoms require escalation: Dysphagia, unexplained weight loss, GI bleeding, or anemia in a GERD patient always warrant upper endoscopy. Reassigning these patients to continued PPI therapy without further workup is the wrong answer.
-
The correct HOB elevation uses a foam wedge, not extra pillows: Stacking pillows flexes the trunk and increases intraabdominal pressure, worsening reflux. A foam wedge elevates the entire upper body from the hips. Correct elevation is 30–45°.
-
Omeprazole + clopidogrel = drug interaction: Both compete for CYP2C19. The preferred PPIs for patients on clopidogrel are lansoprazole, pantoprazole, or rabeprazole. Expect this in a cardiac patient scenario with GERD.
-
H. pylori testing must precede PPI initiation: PPIs suppress H. pylori and reduce urea breath test sensitivity. Order the test first, or hold the PPI for 2 weeks before testing.
-
Gas-bloat syndrome is expected after Nissen fundoplication: The wrap prevents belching; patients will feel distended and may have difficulty vomiting. This is not a complication requiring intervention — it is a predictable post-op finding. Educate preoperatively.
-
Dysphagia after fundoplication: Short-term dysphagia is expected (perioperative edema). Dysphagia persisting beyond 3 months is pathological and requires imaging (barium swallow or EGD to assess wrap integrity).
-
Barrett’s esophagus = metaplasia, not dysplasia: Barrett’s is intestinal metaplasia (a change in cell type). Dysplasia (abnormal cell growth with malignant potential) is a separate finding that can develop within Barrett’s. Know the difference.
-
LINX device restricts MRI: Unlike a pacemaker, LINX can be removed, but MRI is conditionally safe only per manufacturer protocol. Always document LINX implants in medication/device reconciliation.
-
LPR presents without classic heartburn: Up to 40% of LPR patients have no pyrosis. Hoarseness, globus, and chronic throat clearing in a patient who denies “heartburn” should still prompt GERD/LPR workup — particularly if they are a teacher, singer, or have unexplained laryngitis.
Related resources
- Peptic ulcer disease nursing reference — H. pylori pathophysiology, eradication regimens, and gastric vs. duodenal ulcer comparison
- GI bleed nursing reference — Esophageal erosions, varices, and priority hemorrhage interventions
- Pancreatitis nursing reference — Concurrent GI assessment and shared monitoring priorities
- Nursing lab values cheat sheet — Electrolytes including magnesium (relevant for long-term PPI monitoring)
- Drug classifications nursing reference — PPI and H2 blocker pharmacology in context